Cancer Research Horizons

📢 Seed Fund expansion ⭐ We’re excited to announce the expansion of our Seed Fund to £25m, enabling us to invest in more innovative oncology start-ups and at increased scale. This has been made possible by a generous £10m philanthropic donation, which takes us closer to our £30m target. This game-changing support will help us translate more groundbreaking research into real-world benefits, bridging the gap between scientific discovery and life-saving cancer treatments. Read more: https://bit.ly/41xAF74 If you would like to get in touch about the Seed Fund, please contact [email protected]    #OnMyHorizon Phil Masterson Iain Foulkes Tony Hickson Tanya Hughes Tanya Moore 

Your research can be transformational - in more ways than you think 🏆 Back in March, Kirsten McAulay and Alessio Ciulli received an Innovation and Entrepreneurship Award for their industry-academia partnership with Boehringer Ingelheim to develop drugs against ‘undruggable’ drivers of cancer progression. Their win boosted their exciting project to new heights and inspired a new generation of entrepreneurs. Next year, that could be you. Be the first to know when nominations open in early 2025 ➡️ https://bit.ly/4iF7XqT   #OnMyHorizon #IEAwards2025 Alessia Errico PhD MBA Juliana Callaghan University of Dundee

When great minds come together, ideas can thrive 💡 Year after year, our Innovation Summit only gets better. Watch Tiffany S. Ma, DPhil (PhD), Simon Boulton, Andrea Taylor and Sânziana Foia talk about their highlights from last month’s Summit 👇 Thank you all for inspiring our community. We’re excited for next year already! #OnMyHorizon #InnovationSummit24 #EntrepreneurJourney #StartUp #EntrepreneurialTraining Edinburgh Innovations GambitBio The Francis Crick Institute Juliana Callaghan Alessia Errico PhD MBA Cigdem Selli (Chee-them Sally), PhD Phil Berry Joy Shih,Leia Jones

After a tumultuous 2024, all eyes are on where the dust will settle. 🌪 Here, six of our experts share their predictions for 2025, including insights on policy shifts, academic translation, novel cancer therapies, and investment opportunities. 🔗 Read the full article here: https://bit.ly/3ZzqhZI Thank you to Tony Hickson, Alessia Errico PhD MBA, George Tzircotis, Rachel Grimley, Hamish Ryder, and Tanya Moore for sharing your valuable insights. 💭 #OnMyHorizon #LifeSciences #CancerResearch #Biotech #2025Predictions #Innovation #Oncology #Investments #Therapeutics 

 Apply by 13 January 🚨 New year, new opportunities to make an impact beyond the lab. If you're a researcher in #PaediatricOncology, join the first Translational Medicine Certificate Course for Cancers in Young Children and Young Adults. You can look forward to:  💡 4 days of interactive sessions in Toronto  🤝Personalised mentoring  💬 Inspiring keynote speakers  👌 Sponsorship for up to 7 #ChildhoodCancer researchers  Contact our team to apply: email [email protected] or DM Joy Shih,. Created with our partners Eureka Institute for Translational Medicine, University of Toronto and Oncode Institute.     Juliana Callaghan Alessia Errico PhD MBA #OnMyHorizon #EntrepreneurialTraining #EntrepreneurJourney 

🌟 Exciting partnership announcement! 🌟 We are thrilled to announce a new collaboration with the UK’s national synchrotron, Diamond Light Source, aimed at accelerating cancer drug discovery through fragment-based screening.     By leveraging Diamond’s state-of-the-art synchrotron technology and our recognised in-house drug discovery expertise, we will accelerate the identification of potent cancer treatment candidates and drive transformative collaborative projects with pharma and biotech partners across the industry. Thank you to all at Newcastle University and Diamond Light Source who have made this collaboration possible. Can’t wait to see what we achieve together! 🚀 Find out more here: 👉 https://bit.ly/4g7Et3f #OnMyHorizon  Newcastle University, Diamond Light Source, Andrew Turnbull, Elizabeth Shotton

🚨 New publication alert! 🚨 Excited to share that first-in-class autotaxin inhibitor IOA-289 disrupts tumour-supporting signals in the tumour microenvironment of pancreatic cancer. A big round of applause to our colleagues who published this study in collaboration with our portfolio company, iOnctura, demonstrating the drug's potential as a new anti-cancer tool. 🌟 📰 Check out the abstract here: https://bit.ly/4f3RXvM     #OnMyHorizon  Fanny Volat, Ragini Medhi, Marcel Deken, Catherine Pickering, Lars van der Veen, Michael L., David Seeberger Image credit: Anne Weston, EM STP, The Francis Crick Institute

A perfect ending to an insightful day – and just before a great networking session 🤝! Our Associate Director of Ventures, Phil Masterson, chaired the closing panel at #GenesisLondon2024, where we invited investors Anne Horgan (nee Nguyen), Kerstin Papenfuss, PhD MBA, Markus Dietrich, PhD, Jonathan Tobin and Laura A. Lane to share their tips for entrepreneurs looking for investment. 💭 #OnMyHorizon One Nucleus, Tony Jones, Prashant Shah, Freya Parry, Kayvan Richter, Lynne Trowbridge, Janet Morgan, Daniel Gooch, Natalie K., Katja Stout, Katie Sloan, Torquil Jackson, Esmé Walters, Tanya Hughes, Eli Lilly and Company, Cambridge Innovation Capital, Deep Science Ventures, Hadean Ventures, Brandon Capital 

"Two decades of solid investments by the government has seen universities' tech transfer offices really competing with those in the United States".   Our Chief Business Officer, Tony Hickson took to the stage at #GenesisLondon24 for an insightful conversation with Tim Ehrlich, Sarah Haywood, David Stubbs, Eric Mayes and George Freeman FRSA MP about the future of the UK life sciences sector and how important steady, long-term investment is to sector growth. Are you at the conference? Come say hi 👋 #OnMyHorizon One Nucleus Freya Parry Kayvan Richter Lynne Trowbridge Janet Morgan Tony Jones Daniel Gooch Natalie K. Katja Stout Katie Sloan Torquil Jackson Esmé Walters Tanya Hughes

Collaboration update⭐ Excited to announce that yesterday at the #DutchEconomicMission, we officially expanded our ongoing alliance with the Oncode Institute to include the Oncode Accelerator! The Accelerator is a consortium of more than 30 private and public partners on a mission to outsmart cancer. Their involvement brings a wealth of new oncology expertise leveraging well-defined patient cohorts, organoid models and AI platforms to de-risk and accelerate preclinical drug discovery and therapy development. 🚀 Many thanks to Minister Reinette Klever for hosting the ceremonial signing. Find out more about the partnership here: 👉 https://lnkd.in/d8ptCz-d Jan Paul Medema, Chris De Jonghe, Tony Hickson 📷 pbmedia #OnMyHorizon, #AI, #Organoids, #Collaboration